- Home
- KOSS vs TLSA Comparison
KOSS vs TLSA Comparison
Compare KOSS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- TLSA
- Stock Information
- Founded
- KOSS 1953
- TLSA 2013
- Country
- KOSS United States
- TLSA United Kingdom
- Employees
- KOSS N/A
- TLSA N/A
- Industry
- KOSS Consumer Electronics/Appliances
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- TLSA Health Care
- Exchange
- KOSS Nasdaq
- TLSA Nasdaq
- Market Cap
- KOSS 57.5M
- TLSA 187.0M
- IPO Year
- KOSS N/A
- TLSA 2000
- Fundamental
- Price
- KOSS $5.70
- TLSA $1.67
- Analyst Decision
- KOSS
- TLSA
- Analyst Count
- KOSS 0
- TLSA 0
- Target Price
- KOSS N/A
- TLSA N/A
- AVG Volume (30 Days)
- KOSS 77.6K
- TLSA 334.2K
- Earning Date
- KOSS 10-30-2025
- TLSA 05-06-2025
- Dividend Yield
- KOSS N/A
- TLSA N/A
- EPS Growth
- KOSS N/A
- TLSA N/A
- EPS
- KOSS N/A
- TLSA N/A
- Revenue
- KOSS $12,624,170.00
- TLSA N/A
- Revenue This Year
- KOSS N/A
- TLSA N/A
- Revenue Next Year
- KOSS N/A
- TLSA N/A
- P/E Ratio
- KOSS N/A
- TLSA N/A
- Revenue Growth
- KOSS 2.93
- TLSA N/A
- 52 Week Low
- KOSS $4.00
- TLSA $0.63
- 52 Week High
- KOSS $8.59
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- KOSS 43.53
- TLSA 43.49
- Support Level
- KOSS $5.60
- TLSA $1.63
- Resistance Level
- KOSS $5.91
- TLSA $1.88
- Average True Range (ATR)
- KOSS 0.24
- TLSA 0.16
- MACD
- KOSS -0.08
- TLSA -0.01
- Stochastic Oscillator
- KOSS 9.26
- TLSA 32.65
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.